- Repligen (NASDAQ:RGEN) Q4 results: Revenues: $25.6M (+19.6%); Operating Income: $2.9M (+107.1%); Net Income: $5M; EPS: $0.15; Non-GAAP EPS: $0.08 (+14.3%).
-
2016 results: Revenues: $104.5M (+25.1%); Operating Income: $16M (+15.9%); Net Income: $11.7M (+25.8%); EPS: $0.34 (+21.4%); Non-GAAP EPS: $0.44 (+10.0%); Quick Assets: $141.8M (+93.2%).
-
2017 Guidance: Revenues: $121M - 126M; GAAP income from operations: $24M - 26M; Adjusted income from operations: $27M - 29M; GAAP net income: $11M - 13M; Adjusted net income: $18M - 20M; GAAP EPS: $0.35 - 0.40; non-GAAP EPS: $0.54 - 0.59; EBITDA and Adjusted EBITDA: $31M - 33M.